Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 570932생성일: 2026년 10월 25일
Temozolomide → 3-Methyl-8-(4-phenyloxazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one
https://huagongshe.com/reaction/570932
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Temozolomide | HCID 5394 | — |
| 반응물 | Phenacyl bromide | HCID 6259 | — |
| 생성물 | 3-Methyl-8-(4-phenyloxazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one | HCID 49870768 | 1% |
반응 단계
Temozolomide (0.200 g; 1.03 mmol) and 2-bromoacetophenone (0.246 g; 1.24 mmol) were stirred in a sealed tube under nitrogen, and heated to 130° C. for 1 hour. The mixture was cooled, and then concentrated in vacuo before being applied directly to the head of a chromatography column (SiO2) and purified by column chromatography (DCM:MeOH, 5:1), to give the title compound as a yellow powder (0.003 g; 1%). δH (DMSO-d6) 8.97 (1H, s), 8.88 (1H, s), 7.91 (2H, t, J=7.4), 7.50 (2H, t, J=7.4), 7.39 (1H, t, J=7.4), 3.90 (3H, s).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09024018B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_05 |
|---|
| ORD ID | ord-b539e4404e004055ae843be7b7fe575d |
|---|
| 출처 메모 | uspto-grants-2015_05 |
|---|